Moving the second dose of measles-mumps-rubella vaccine to school entry: implications for control of rubella.
Heath
T C
TC
National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, New Children's Hospital, Parramatta, New South Wales.
Burgess
M A
MA
Forrest
J M
JM
D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D003140:Communicable Disease Control; D004334:Drug Administration Schedule; D006801:Humans; D007115:Immunization Schedule; D008458:Measles Vaccine / Q000008:administration & dosage*; D022542:Measles-Mumps-Rubella Vaccine; D009108:Mumps Vaccine / Q000008:administration & dosage*; D012409:Rubella / Q000517:prevention & control*; D012411:Rubella Vaccine / Q000008:administration & dosage*; D012574:Schools; D017778:Vaccines, Combined / Q000008:administration & dosage
D008458:Measles Vaccine; D022542:Measles-Mumps-Rubella Vaccine; D009108:Mumps Vaccine; D012411:Rubella Vaccine; D017778:Vaccines, Combined